These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38396242)

  • 41. Recombinant invasive Lactococcus lactis can transfer DNA vaccines either directly to dendritic cells or across an epithelial cell monolayer.
    de Azevedo M; Meijerink M; Taverne N; Pereira VB; LeBlanc JG; Azevedo V; Miyoshi A; Langella P; Wells JM; Chatel JM
    Vaccine; 2015 Sep; 33(38):4807-12. PubMed ID: 26241952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimized expression of Helicobacter pylori ureB gene in the Lactococcus lactis nisin-controlled gene expression (NICE) system and experimental study of its immunoreactivity.
    Zhang XJ; Duan G; Zhang R; Fan Q
    Curr Microbiol; 2009 Apr; 58(4):308-14. PubMed ID: 19238485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
    Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. M cell-targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis.
    Takahashi K; Yano A; Watanabe S; Langella P; Bermúdez-Humarán LG; Inoue N
    Appl Microbiol Biotechnol; 2018 Dec; 102(24):10703-10711. PubMed ID: 30310964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Designing an efficient multi-epitope oral vaccine against Helicobacter pylori using immunoinformatics and structural vaccinology approaches.
    Nezafat N; Eslami M; Negahdaripour M; Rahbar MR; Ghasemi Y
    Mol Biosyst; 2017 Mar; 13(4):699-713. PubMed ID: 28194462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model.
    Zhou WY; Shi Y; Wu C; Zhang WJ; Mao XH; Guo G; Li HX; Zou QM
    Vaccine; 2009 Aug; 27(36):5013-9. PubMed ID: 19446591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.
    Guo L; Yin R; Liu K; Lv X; Li Y; Duan X; Chu Y; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3495-507. PubMed ID: 24370888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: An in silico approach.
    Meza B; Ascencio F; Sierra-Beltrán AP; Torres J; Angulo C
    Infect Genet Evol; 2017 Apr; 49():309-317. PubMed ID: 28185986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of Helicobacter pylori CagL gene in Lactococcus lactis MG1363 and evaluation of its immunogenicity as an oral vaccine in mice.
    Aliramaei MR; Khorasgani MR; Rahmani MR; Zarkesh Esfahani SH; Emamzadeh R
    Microb Pathog; 2019 Dec; 142():103926. PubMed ID: 31838174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model.
    Guo L; Liu K; Xu G; Li X; Tu J; Tang F; Xing Y; Xi T
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1437-44. PubMed ID: 22569640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of Helicobacter pylori cag12 gene in Lactococcus lactis MG1363 and its oral administration to induce systemic anti-Cag12 immune response in mice.
    Kim SJ; Jun DY; Yang CH; Kim YH
    Appl Microbiol Biotechnol; 2006 Sep; 72(3):462-70. PubMed ID: 16586107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Embedding of exogenous B cell epitopes on the surface of UreB structure generates a broadly reactive antibody response against Helicobacter pylori.
    Ji Q; Ma J; Wang S; Liu Q
    Immunology; 2024 Feb; 171(2):212-223. PubMed ID: 37899627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unraveling the crystal structure of the HpaA adhesin: insights into cell adhesion function and epitope localization of a
    Martini C; Araba V; Beniani M; Armoa Ortiz P; Simmons M; Chalbi M; Mellouk A; El Bakkouri M; Calmettes C
    mBio; 2024 Mar; 15(3):e0295223. PubMed ID: 38376163
    [No Abstract]   [Full Text] [Related]  

  • 54. Mucosal and systemic immune responses elicited by recombinant Lactococcus lactis expressing a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis.
    Torkashvand A; Bahrami F; Adib M; Ajdary S
    Microb Pathog; 2018 Jul; 120():155-160. PubMed ID: 29738814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
    Daniel C; Titecat M; Poiret S; Cayet D; Boutillier D; Simonet M; Sirard JC; Lemaître N; Sebbane F
    Vaccine; 2016 Nov; 34(47):5762-5767. PubMed ID: 27742220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral immunization with recombinant Mycobacterium smegmatis expressing the outer membrane protein 26-kilodalton antigen confers prophylactic protection against Helicobacter pylori infection.
    Lü L; Zeng HQ; Wang PL; Shen W; Xiang TX; Mei ZC
    Clin Vaccine Immunol; 2011 Nov; 18(11):1957-61. PubMed ID: 21900527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthetic Lipopeptide Enhances Protective Immunity Against
    Xue RY; Guo MF; Guo L; Liu C; Li S; Luo J; Nie L; Ji L; Ma CJ; Chen DQ; Sun S; Jin Z; Zou QM; Li HB
    Front Immunol; 2019; 10():1372. PubMed ID: 31258538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune responses elicited in mice with recombinant Lactococcus lactis expressing F4 fimbrial adhesin FaeG by oral immunization.
    Liu S; Li Y; Xu Z; Wang Y
    Vet Res Commun; 2010 Aug; 34(6):491-502. PubMed ID: 20532816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit.
    Guo L; Li X; Tang F; He Y; Xing Y; Deng X; Xi T
    Appl Microbiol Biotechnol; 2012 Mar; 93(5):1937-45. PubMed ID: 22134639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peroral immunization with Helicobacter pylori adhesin protein genetically linked to cholera toxin A2B subunits.
    Kim BO; Shin SS; Yoo YH; Pyo S
    Clin Sci (Lond); 2001 Mar; 100(3):291-8. PubMed ID: 11222115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.